| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-26 |
| filingDate |
2002-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_941a94f199317c472f4a9f512938f5ee |
| publicationDate |
2004-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-0212043-A |
| titleOfInvention |
The compound or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof, process for preparing it, pharmaceutical composition, use thereof, and methods for producing an elevation of pdh activity in a warm-blooded animal, and for treating diabetes mellitus in a warm-blooded animal |
| abstract |
"COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT OR HYDROLYZABLE ESTER IN VIVO, PROCESS TO PREPARE, PHARMACEUTICAL COMPOSITION, USE OF THEREOF, AND METHODS TO PRODUCE A RISE IN PDH ACTIVITY TO A SANGAR ANIMAL DIMENSION IN A HOT BLOOD ANIMAL ". Compounds of Formula (I) wherein R is methyl or mesyl are described; and their pharmaceutically acceptable salts and in vivo hydrolysable esters. Processes for their preparation, pharmaceutical compositions containing them and their use in producing an increase in PDH activity in a warm-blooded animal are also described. |
| priorityDate |
2001-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |